<DOC>
	<DOC>NCT01968395</DOC>
	<brief_summary>The objective of this study is to conduct a population pharmacokinetic analysis of caspofungin in a population of patients with moderate and severe acute alcoholic hepatitis or liver disease with Child-Pugh score B and C in order to better characterize pharmacokinetic parameters in case of moderate and severe liver dysfunction.</brief_summary>
	<brief_title>Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure</brief_title>
	<detailed_description>patients admitted for alcoholic hepatitis or decompensated cirrhosis and Child-Pugh score 7-9 and 10-15 will be included; all patients without invasive aspergillosis.</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Liver failure ChildPugh B and C Cachexia (BMI &lt; 15 kg/mÂ²) Pregnancy HIV Hepatitis C patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>